These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 12071349

  • 1. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain.
    Kaneko K, Nakamura A, Yoshida K, Kametani F, Higuchi K, Ikeda S.
    Free Radic Res; 2002 Mar; 36(3):303-6. PubMed ID: 12071349
    [Abstract] [Full Text] [Related]

  • 2. Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia.
    Kaneko K, Yoshida K, Arima K, Ohara S, Miyajima H, Kato T, Ohta M, Ikeda SI.
    J Neuropathol Exp Neurol; 2002 Dec; 61(12):1069-77. PubMed ID: 12484569
    [Abstract] [Full Text] [Related]

  • 3. Molecular and pathological basis of aceruloplasminemia.
    Kono S, Miyajima H.
    Biol Res; 2006 Dec; 39(1):15-23. PubMed ID: 16629161
    [Abstract] [Full Text] [Related]

  • 4. Aceruloplasminemia, an iron metabolic disorder.
    Miyajima H.
    Neuropathology; 2003 Dec; 23(4):345-50. PubMed ID: 14719552
    [Abstract] [Full Text] [Related]

  • 5. Aceruloplasminemia.
    Miyajima H.
    Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
    [Abstract] [Full Text] [Related]

  • 6. Increased lipid peroxidation in the brains of aceruloplasminemia patients.
    Yoshida K, Kaneko K, Miyajima H, Tokuda T, Nakamura A, Kato M, Ikeda S.
    J Neurol Sci; 2000 Apr 15; 175(2):91-5. PubMed ID: 10831768
    [Abstract] [Full Text] [Related]

  • 7. Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia.
    Oide T, Yoshida K, Kaneko K, Ohta M, Arima K.
    Neuropathol Appl Neurobiol; 2006 Apr 15; 32(2):170-6. PubMed ID: 16599945
    [Abstract] [Full Text] [Related]

  • 8. Aceruloplasminemia, an inherited disorder of iron metabolism.
    Miyajima H, Takahashi Y, Kono S.
    Biometals; 2003 Mar 15; 16(1):205-13. PubMed ID: 12572680
    [Abstract] [Full Text] [Related]

  • 9. Redox active iron accumulation in aceruloplasminemia.
    Gonzalez-Cuyar LF, Perry G, Miyajima H, Atwood CS, Riveros-Angel M, Lyons PF, Siedlak SL, Smith MA, Castellani RJ.
    Neuropathology; 2008 Oct 15; 28(5):466-71. PubMed ID: 18282164
    [Abstract] [Full Text] [Related]

  • 10. Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemia brains.
    Miyajima H, Kono S, Takahashi Y, Sugimoto M.
    Blood Cells Mol Dis; 2002 Oct 15; 29(3):433-8. PubMed ID: 12547232
    [Abstract] [Full Text] [Related]

  • 11. Type-dependent oxidative damage in frontotemporal lobar degeneration: cortical astrocytes are targets of oxidative damage.
    Martínez A, Carmona M, Portero-Otin M, Naudí A, Pamplona R, Ferrer I.
    J Neuropathol Exp Neurol; 2008 Dec 15; 67(12):1122-36. PubMed ID: 19018247
    [Abstract] [Full Text] [Related]

  • 12. [Neuronal cell damage in aceruloplasminemia].
    Miyajima H.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct 15; 20(4):161-7. PubMed ID: 11215401
    [Abstract] [Full Text] [Related]

  • 13. Aceruloplasminemia.
    Kono S.
    Curr Drug Targets; 2012 Aug 15; 13(9):1190-9. PubMed ID: 22515740
    [Abstract] [Full Text] [Related]

  • 14. Two-dimensional gel electrophoresis of human brain proteins. IV. Disorders of glial proliferation and a polymorphism of glial fibrillary acidic protein--GFAP Duarte.
    Comings DE.
    Clin Chem; 1982 Apr 15; 28(4 Pt 2):805-12. PubMed ID: 7074873
    [Abstract] [Full Text] [Related]

  • 15. Microglia and astroglia prevent oxidative stress-induced neuronal cell death: implications for aceruloplasminemia.
    Oshiro S, Kawamura K, Zhang C, Sone T, Morioka MS, Kobayashi S, Nakajima K.
    Biochim Biophys Acta; 2008 Feb 15; 1782(2):109-17. PubMed ID: 18187051
    [Abstract] [Full Text] [Related]

  • 16. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Xu X, Pin S, Gathinji M, Fuchs R, Harris ZL.
    Ann N Y Acad Sci; 2004 Mar 15; 1012():299-305. PubMed ID: 15105274
    [Abstract] [Full Text] [Related]

  • 17. Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease.
    Muntané G, Dalfó E, Martínez A, Rey MJ, Avila J, Pérez M, Portero M, Pamplona R, Ayala V, Ferrer I.
    J Neurochem; 2006 Oct 15; 99(1):177-85. PubMed ID: 16987245
    [Abstract] [Full Text] [Related]

  • 18. [Aceruloplasminemia].
    Miyajima H.
    Rinsho Shinkeigaku; 2000 Dec 15; 40(12):1290-2. PubMed ID: 11464482
    [Abstract] [Full Text] [Related]

  • 19. Increased vulnerability to rotenone-induced neurotoxicity in ceruloplasmin-deficient mice.
    Kaneko K, Hineno A, Yoshida K, Ikeda S.
    Neurosci Lett; 2008 Nov 28; 446(1):56-8. PubMed ID: 18804145
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of human brain damage in fire fatality by quantification of basic fibroblast growth factor (bFGF), glial fibrillary acidic protein (GFAP) and single-stranded DNA (ssDNA) immunoreactivities.
    Wang Q, Ishikawa T, Michiue T, Zhu BL, Maeda H.
    Forensic Sci Int; 2011 Sep 10; 211(1-3):19-26. PubMed ID: 21530117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.